Trends Endocrinol Metab 2020;31:410-21.ArticlePubMed 136
Today, two GLP-1RAs, liraglutide and semaglutide, are approved for the purpose of weight loss as an adjunct to lifestyle therapy
Your Next Steps Radiofrequency skin tightening post GLP-1 weight loss is an excellent practical option for many looking to combat loose skin and facial volume loss
Vagal glucoreceptors in the small intestine of the cat
Patients with type 2 diabetes or obesity who meet criteria for GLP-1 therapy may experience additional lipid benefits, particularly those with mixed dyslipidaemia, metabolic syndrome, or established cardiovascular disease
Single GLP-1 receptor agonists act on one incretin pathway, while dual GIP/GLP-1 agonists target two pathways